Current therapy and drug resistance in metastatic castration-resistant prostate cancer - Cai, M.; Song, X. L.; Li, X. A.; Chen, M.; Guo, J.; Yang, D. H. (Drug Resist Updat, 2023)

Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs - Rizzo, M. (Biochim Biophys Acta Rev Cancer, 2021)

Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism - Chen, L.; Song, Y.; Hou, T.; Li, X.; Cheng, L.; Li, Y. (J Exp Clin Cancer Res, 2022)

Importins and exportins as therapeutic targets in cancer - Mahipal, A.; Malafa, M. (Pharmacol Ther, 2016)

XPO1-dependent nuclear export as a target for cancer therapy - Azizian, N. G.; Li, Y. (J Hematol Oncol, 2020)

Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy - Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Chavan, S. S. (Cancer Res, 2022)

Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer - Inoue, A.; Robinson, F. S.; Minelli, R.; Tomihara, H.; Rizi, B. S.; Rose, J. L. (Gastroenterology, 2021)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia - Walker, J. S.; Hing, Z. A.; Harrington, B.; Baumhardt, J.; Ozer, H. G.; Lehman, A. (J Hematol Oncol, 2021)

Targeting nuclear exporter protein XPO1/CRM1 in gastric cancer - Sexton, R.; Mahdi, Z.; Chaudhury, R.; Beydoun, R.; Aboukameel, A.; Khan, H. Y. (Int J Mol Sci, 2019)

School vaccination: the precursor to school medical inspection - Duffy, J. (J Hist Med Allied Sci, 1978)

XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa) - Gravina, G. L.; Tortoreto, M.; Mancini, A.; Addis, A.; Cesare, E.; Lenzi, A. (J Hematol Oncol, 2014)

Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma - Lin, J.; Hou, Y.; Huang, S.; Wang, Z.; Sun, C.; Wang, Z. (Mol Carcinog, 2019)

Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma - Liang, X. T.; Pan, K.; Chen, M. S.; Li, J. J.; Wang, H.; Zhao, J. J. (J Gastroenterol Hepatol, 2011)

Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer - Shigeyasu, K.; Okugawa, Y.; Toden, S.; Boland, C. R.; Goel, A. (Clin Cancer Res, 2017)

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1 - Zhu, C.; Kim, S. J.; Mooradian, A.; Wang, F.; Li, Z.; Holohan, S. (Cell Rep, 2021)

The role of exportin 6 in cytoskeletal-mediated cell death and cell adhesion in human non-small-cell lung carcinoma cells following doxorubicin treatment - Izdebska, M.; Gagat, M.; Grzanka, D.; Halas, M.; Grzanka, A. (Folia Histochem Cytobiol, 2014)

Serum response factor-mediated gene regulation in a drosophila visual working memory - Thran, J.; Poeck, B.; Strauss, R. (Curr Biol, 2013)

Differentiation-associated alteration in gene expression of importins and exportins in human leukemia HL-60 cells - Suzuki, T.; Ishigami, Y.; Okada, N.; Kaneko, A.; Fukutomi, R.; Isemura, M. (Biomed Res, 2008)

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness - Munoz-Galvan, S.; Felipe-Abrio, B.; Verdugo-Sivianes, E. M.; Perez, M.; Jimenez-Garcia, M. P.; Suarez-Martinez, E. (Mol Cancer, 2020)

Mechanisms of Hippo pathway regulation - Meng, Z.; Moroishi, T.; Guan, K. L. (Genes Dev, 2016)

ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling - Yu, S.; Zhang, M.; Huang, L.; Ma, Z.; Gong, X.; Liu, W. (Aging, 2019)

The Hippo signaling pathway in stem cell biology and cancer - Mo, J. S.; Park, H. W.; Guan, K. L. (EMBO Rep, 2014)

Dysregulation of the Hippo pathway signaling in aging and cancer - Yeung, Y. T.; Guerrero-Castilla, A.; Cano, M.; Munoz, M. F.; Ayala, A.; Arguelles, S. (Pharmacol Res, 2019)

Aspirin attenuates YAP and beta-catenin expression by promoting beta-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer - Ma, J.; Fan, Z.; Tang, Q.; Xia, H.; Zhang, T.; Bi, F. (Cell Death Dis, 2020)

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1 - Wang, Y.; Lieberman, R.; Pan, J.; Zhang, Q.; Du, M.; Zhang, P. (Mol Cancer, 2016)

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer - Matsuda, Y.; Narita, S.; Nara, T.; Mingguo, H.; Sato, H.; Koizumi, A. (BMC Cancer, 2020)

CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling - Lai, C. J.; Lin, C. Y.; Liao, W. Y.; Hour, T. C.; Wang, H. D.; Chuu, C. P. (Cells, 2019)

Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways - Lu, X.; Yang, F.; Chen, D.; Zhao, Q.; Chen, D.; Ping, H. (Int J Biol Sci, 2020)

Ran-dependent nuclear export mediators: a structural perspective - Guttler, T.; Gorlich, D. (Embo J, 2011)

Protein localization in disease and therapy - Hung, M. C.; Link, W. (J Cell Sci, 2011)

Elevated XPO6 expression as a potential prognostic biomarker for prostate cancer recurrence - Hao, J.; Chiang, Y. T.; Gout, P. W.; Wang, Y. (Front Biosci (Schol Ed), 2016)

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP - Liu-Chittenden, Y.; Huang, B.; Shim, J. S.; Chen, Q.; Lee, S. J.; Anders, R. A. (Genes Dev, 2012)

The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway - Yao, Y.; Liu, Z.; Huang, S.; Huang, C.; Cao, Y.; Li, L. (Cell Death Discov, 2022)